Studying the role of BCL2 and MYC in the pathogenesis of diffuse large B cell lymphoma

Approximately 30% of patients with diffuse large B-cell lymphoma (DLBCL) co-express BCL2 and MYC, known as double-expressor lymphomas (DEL). These lymphomas associate with poorer prognosis and response to standard-of-care R-CHOP, and a preferred therapeutic alternative has not been identified yet...

Full description

Bibliographic Details
Main Authors: Sánchez, J. (Javier), Martinez-Climent, J.A. (José Ángel), Roa, S. (Sergio)
Format: info:eu-repo/semantics/doctoralThesis
Language:eng
Published: Universidad de Navarra 2023
Subjects:
Online Access:https://hdl.handle.net/10171/68058